Trial intelligence / Profile preview

Nabilone for Diabetic Peripheral Neuropathic Pain

NCT01035281Phase 3Unknown

Sponsor
University of Calgary
Start
Jan 2008
Primary completion
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nabilone in diabetic polyneuropathy (DPN), sponsored by University of Calgary. Status: unknown.

02

Drugs

nabilone
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on NCT01035281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01035281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call